Castration prevents calcium channel blocker-induced gingival hyperplasia in beagle dogs

Human and Experimental Toxicology

Volumn 17, Issue 7, 1998, Pages 396-402

  Dayan, Dan ^a   Kozlovsky, Avital ^a   Tal, Haim ^a   Kariv, Noam ^a   Shemesh, Mordechai ^b   Nyska, Abraham ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Calcium channel blocker; Castration; Gingival hyperplasia

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; OXODIPINE; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; CASTRATION; CONTROLLED STUDY; DOG; GINGIVA; GINGIVA HYPERPLASIA; MALE; NONHUMAN; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ANIMALIA; CANIS FAMILIARIS;

EID: 0031693796     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719801700706     Document Type: Article

References (34)

1. Hassel T. Drug-induced gingival overgrowth: Old problem, new problem. Critical Reviews Oral Biology and Medicine 1991; 2: 103-137.
2. Sooriymoorthy M, Gover DB, Eley Bm. Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporin. Journal of Periodontal Research 1990; 25: 25-30.
3. Rappaport SC, Viitek J, Altman K, Gordon GG et al.. Sex differences in the metabolism of androgens by human gingiva. Journal of Dental Research 1976; 55: 1371.
4. Southern AL, Rappaport SC, Gordon GG, Viltek J. Specific 5α-dihydrotestosterone receptors in human gingiva. Journal of Clinical Endocrinology and Metabolism 1978; 47: 1378-1382.
5. Ojanatko A, Neinstedt W, Harri P. Metabolism of testosterone by human healthy and inflamed gingiva (in vitro). Archives of Oral Biology 1980; 25: 481-484.
6. Galiano A. Oxodipine. Drugs of the Future 1987; 12: 623-624.
7. Waner T, Nyska A, Nyska M, Sela M et al. Gingival hyperplasia in dogs induced by oxodipine, a calcium channel blocker. Toxicologic Pathology 1988; 16: 327-332.
8. Nyska A, Waner T, Pirak M, Galiano A et al. Gingival hyperplasia in rats induced by oxodipine - a calcium channel blocker. Journal of Periodontal Research 1990; 25: 65-68.
9. Nyska A, Waner T, Zlotogorski A, Pirak M et al. Animal model of human disease. Oxodipine-induced gingival hyperplasia in beagle dogs. American Journal of Pathology 1990; 137: 737-739.
10. Dayan D, Waner T, Tal H, Nyska A. Polarization microscopy of Picrosirius red stained collagen from oxodipine induced hyperplastic gingiva of beagle dogs. International Journal of Experimental Pathology 1993; 74: 225-228.
11. Nyska A Waner T, Shapira S, Skutelski E et al. Thickening of the adrenal zona glomerulosa in dogs induced by oxodipine, a calcium channel blocker. Toxicologic Pathology 1992; 20 549-552.
12. Nyska A, Shemesh M, Tal H, Dayan D. Gingival hyperplasia induced by calcium channel blockers: Mode of action. Medical Hypothesis 1994; 43: 115-118.
13. Crane SW, Smallwood JE, Wensing CJC. Prostate gland and testes. In: Bojrab MJ, Crane SW, Arnoczky SP (eds). Current Techniques of Small Animal Surgery, 2nd edn. Lea & Febiger, Philadelphia, 1984; pp. 369-379.
14. Löe H, Silness J. Periodical disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica 1963; 21: 533-551.
15. Harris TH, Ewart JR. Complication following use of sodium diphenylhydantoinate (Dilantin) therapy. Journal of the Oklahoma State Medical Association 1942; 35: 365.
16. Addy V, McElnay JC, Eyre DG, Campbell N et al. Risk factors in phenytoin-induced gingival hyperplasia. Journal of Periodontology 1983; 54: 373-377.
17. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica 1964; 24: 747-759.
18. Shore LS, Gurevitz M, Shemesh M. Estrogen as an environmental pollutant. Bulletin of Environmental Contamination and Toxicology 1993; 51: 361-366.
19. Shore LS, Shemesh M. Altered steroidogenesis by the fetal bovine freematin ovary. Journal of Reproduction and Fertility 1981; 63: 309-314.
20. Parker MH, Newman II N. Polymerase chain reaction analysis of estrogen and androgen receptor expression in human gingival and periodontal tissue. Archives of Oral Biology 1996; 41: 979-983.
21. Southern AL, Rappaport SC, Gordon GG, Vittek J. Specific 5 alpha-dihydrotestosterone receptors in human gingiva. Journal of Clinical Endocrinology and Metabolism 1978; 47: 1378-1382.
22. Kassa SC, Soory M. The response of human gingival fibroblasts to interleukin-1 (IL-1) in their metabolic conversion of two androgenic substances. Archives of Oral Biology 1995; 40: 979-981.
23. Kassa SC, Soory M. The effect of interleukin-1 (IL-1) on androgen metabolism in human gingival tissue (HGT) and periodontal ligament (PDL). Journal of Clinical Periodontology 1996; 23: 419-424.
24. Bullough WS, Van Oordt GJ. The mitogenic actions of testosterone proprionate and oestrone on the epidermis of the adult male mouse. Acta Endocrinologica 1950; 4: 291-305.
25. Nielsen SW, Aftosmis J. Canine perianal gland tumors. Journal of the American Veterinary Medical Association 1964; 144: 127-135.
26. Zackheim HS. Effect of castration on the induction of epidermal neoplasms in male mice by topical methylcholathrene. Journal of Investigative Dermatology 1970; 54: 479-482.
27. English HF, Kyprianou N, Isaacs JT. Relationship between DNA fragmentation and apoptosis in programmed cell death in the rat prostate following castration. Prostate 1989; 15: 233-250.
28. Terada N, Yamamoto R, Takada T, Taniguchi H et al. Inhibitory effect of androgen on cell death of mouse uterine epithelium. Journal of Steroid Biochemistry 1990; 36: 305-310.
29. Bosland MC, Prinsen MK, Riverson A, Weisburger J et al. Induction of skin and thyroid tumors in the male rats by N-methyl-N-nitro-sourea after sequential treatment with cyproterone acetate and testosterone proprionate: Effects of castration, rat strain and time of carcinogen injection. Carcinogenesis 1992; 13: 669-674.
30. Imanishi O, Fujisawa M, Matsumoto O, Kamidono O et al. Androgenic regulation of enzymes involved in DNA synthesis in epididymis of young rat. Journal of Reproduction and Fertility 1992; 96: 355-361.
31. Navarro MA, Juan L, Bonnin MY. Salivary testosterone: Relationship to total and free testosterone in serum. Clinical Chemistry 1986; 32: 231-232.
32. Dabbs JM, Jr. Salivary testosterone measurements: Reliability across hours, days and weeks. Physiology and Behavior 1990; 48: 83-86.
33. Dabbs JM, Jr. Salivary testosterone measurements: Collecting, storing and mailing saliva samples. Physiology and Behavior 1991; 49: 815-817.
34. Dabbs JM, Jr. Salivary testosterone measurements in behavioral studies. Annals of the New York Academy of Science 1992; 694: 177-183.